Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Psychopharmacology (Berl). 2012 Feb 4;222(2):353–365. doi: 10.1007/s00213-012-2650-z

Table 1.

Mean ± SEM number of sessions to complete training phases 1 and 2 for Go/No-go task and to attain stable performance under baseline conditions

Strain Na Phase lb Phase 2c Baselined
MALDR Male 9 5.44 ± 0.73 5.00 ± 0.68 19.00 ± 0.94
Female 12 5.75 ± 0.63 2.75 ± 0.58 20.33 ± 0.82
MAHDR Male 11 6.00 ± 0.66 4.18 ± 0.61 20.64 ± 0.85
Female 9 5.00 ± 0.73 3.22 ± 0.67 21.44 ± 0.94
MALSENS Male 12 2.58 ± 0.56 2.00 ± 0.71 28.33 ± 1.72
Female 14 3.00 ± 0.52 2.14 ± 0.65 28.79 ± 1.59
MAHSENS Male 11 4.18 ± 0.59 2.91 ± 0.74 28.55 ± 1.80
Female 13 4.92 ± 0.54 5.46 ± 0.68 23.62 ± 1.65

Notes.

a

Mice that failed to acquire the task at any training phase are excluded (see Results section for number of failures).

b

During Phase 1 there were 60 Go trials and 0 No-Go trials. Each Go cue lasted for 30 seconds. Mice advanced to the Phase 2 of training by responding on at least 30 of the 60 Go trials within 40 minutes for two consecutive sessions. MALSENS mice advanced after fewer sessions that the MAHSENS mice (F(1, 46) = 10.19,p = .003.) No other differences were found.

c

During Phase 2 the Go cue was shortened to 10 s, and mice again had to respond on at least 30 of 60 Go trials within 40 minutes for two consecutive sessions. Again, MALSENS mice advanced more quickly than MAHSENS mice (F(1, 46) = 9.24, p = .004.)

d

The baseline phase consisted of 30 Go trials and 30 No-go trials (see Procedure for full description). Mice attained stable behavior at similar rates, and no significant line differences were observed.